{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:48:08Z","timestamp":1758635288557,"version":"3.40.3"},"publisher-location":"Dordrecht","reference-count":43,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789400745483"},{"type":"electronic","value":"9789400745490"}],"license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-94-007-4549-0_27","type":"book-chapter","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T17:11:56Z","timestamp":1343322716000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Angiogenic Activity of Sera from Interstitial Lung Disease Patients in Relation to Angiotensin-Converting Enzyme Activity"],"prefix":"10.1007","author":[{"given":"T. M.","family":"Zielonka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zycinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chorostowska-Wynimko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Filewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bialas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Obrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Radzikowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Skopinska-Rozewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Demkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.pupt.2006.01.002","volume":"20","author":"KM Antoniou","year":"2007","unstructured":"Antoniou, K. M., Pataka, A., Bouros, D., & Siafakas, N. M. (2007). Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics, 20, 453\u2013461.","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"27_CR2","first-page":"646","volume":"16","author":"ATS","year":"2000","unstructured":"ATS. (2000). Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Journal of Respiratory and Critical Care Medicine, 16, 646\u2013664.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"27_CR3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"ATS\/ERS\/WASOG","year":"1999","unstructured":"ATS\/ERS\/WASOG. (1999). Statement on sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 160, 736\u2013755.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1378\/chest.107.3.706","volume":"107","author":"EA Brice","year":"1995","unstructured":"Brice, E. A., Friedlander, W., Bateman, E. D., & Kirsch, R. E. (1995). Serum angiotensin-converting enzyme activity, concentration, and specific activity granulomatous disease, tuberculosis and COPD. Chest, 107, 706\u2013710.","journal-title":"Chest"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/0190-9622(95)91549-4","volume":"32","author":"M Carlesimo","year":"1995","unstructured":"Carlesimo, M., Giustini, S., Rossi, A., Bonaccorsi, P., & Calvieri, S. (1995). Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. Journal of the American Academy of Dermatology, 32, 866\u2013869.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.ATV.0000149377.90852.d8","volume":"25","author":"TG Ebrahimian","year":"2005","unstructured":"Ebrahimian, T. G., Tamarat, R., Diurez, C., Duriez, M., Levy, B. I., & Silvestre, J. S. (2005). Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 65\u201370.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2174\/1570161043385556","volume":"2","author":"E Escobar","year":"2004","unstructured":"Escobar, E., Rodr\u00edguez-Reyna, T. S., Arrieta, O., & Sotelo, J. (2004). Angiotensin II, cell proliferation and angiogenesis regulator: Biologic and therapeutic implications in cancer. Current Vascular Pharmacology, 2, 385\u2013399.","journal-title":"Current Vascular Pharmacology"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/01.RES.88.1.22","volume":"88","author":"S Fujiyama","year":"2001","unstructured":"Fujiyama, S., Matsubara, H., Nozawa, Y., Maruyama, K., Mori, Y., Tsutsumi, Y., Masaki, H., Uchiyama, Y., Koyama, Y., Nose, A., Iba, O., Tateishi, E., Ogata, N., Jyo, N., Higashiyama, S., & Iwasaka, T. (2001). Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circulation Research, 88, 22\u201329.","journal-title":"Circulation Research"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"10868","DOI":"10.1073\/pnas.94.20.10868","volume":"94","author":"S Gately","year":"1997","unstructured":"Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., Volpert, O., Bouck, N., & Soff, G. A. (1997). The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proceedings of the National Academy of Sciences of the United States of America, 94, 10868\u201310872.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"27_CR43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1164\/ajrccm\/148.2.483","volume":"148","author":"S Gilbert","year":"1993","unstructured":"Gilbert, S., Steinbrech, D. S., Landas, S. K., & Hunninghake, G. W. (1993). Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. American Review of Respiratory Disease, 148(2), 483\u2013486.","journal-title":"American Review of Respiratory Disease"},{"key":"27_CR10","first-page":"228","volume":"59","author":"C Gronhagen-Riska","year":"1978","unstructured":"Gronhagen-Riska, C., Kurppa, K., Fyhrquist, F., & Selroos, O. (1978). Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scandinavian Journal of Respiratory Diseases, 59, 228\u2013231.","journal-title":"Scandinavian Journal of Respiratory Diseases"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ygyno.2008.02.019","volume":"109","author":"D Herr","year":"2008","unstructured":"Herr, D., Rodewald, M., Fraser, H. M., Hack, G., Konrad, R., Kreienberg, R., & Wulff, C. (2008). Potential role of renin-angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecologic Oncology, 109, 418\u2013425.","journal-title":"Gynecologic Oncology"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.mvr.2010.05.007","volume":"80","author":"KH Hiller","year":"2010","unstructured":"Hiller, K. H., Ruile, P., Kraus, G., Bauer, W. R., & Waller, C. (2010). Tissue ACE inhibition improves microcirculation in remote myocardium after coronary stenosis: MR imaging study in rats. Microvascular Research, 80, 484\u2013490.","journal-title":"Microvascular Research"},{"key":"27_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0020-711X(91)90032-I","volume":"23","author":"N Hooper","year":"1991","unstructured":"Hooper, N. (1991). Angiotensin converting enzyme: Implications from molecular biology for its physiological functions. The International Journal of Biochemistry, 23, 641\u2013647.","journal-title":"The International Journal of Biochemistry"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/14712598.6.3.243","volume":"6","author":"K Ino","year":"2006","unstructured":"Ino, K., Shibata, K., Kajiyama, H., Nawa, A., Nomura, S., & Kikkawa, F. (2006). Manipulating the angiotensin system-new approaches to the treatment of solid tumors. Expert Opinion on Biological Therapy, 6, 243\u2013255.","journal-title":"Expert Opinion on Biological Therapy"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1164\/rccm.2405007","volume":"170","author":"MP Keane","year":"2004","unstructured":"Keane, M. P. (2004). Angiogenesis and pulmonary fibrosis: Feast or famine? American Journal of Respiratory and Critical Care Medicine, 170, 207\u2013209.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1161\/STROKEAHA.108.537225","volume":"40","author":"A Kozak","year":"2009","unstructured":"Kozak, A., Ergul, A., El-Remessy, A. B., Johnson, M. H., Machado, L. S., Elewa, H. F., Abdelsaid, M., Wiley, D. C., & Fagan, S. C. (2009). Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke, 40, 1870\u20131876.","journal-title":"Stroke"},{"key":"27_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1164\/rccm.200301-137OC","volume":"168","author":"Y Lacasse","year":"2003","unstructured":"Lacasse, Y., Selman, M., Costabel, U., Dalphin, J. C., Ando, M., Morell, F., Erkinjuntti-Pekkanen, R., Muller, N., Colby, T. V., Schuyler, M., Cormier, Y., & HP Study Group. (2003). Clinical diagnosis of hypersensitivity pneumonitis. American Journal of Respiratory and Critical Care Medicine, 168, 952\u2013958.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","volume":"352","author":"AF Lever","year":"1998","unstructured":"Lever, A. F., Hole, D. J., Gillis, C. R., McCallum, I. R., McInnes, G. T., MacKinnon, P. L., Meredith, P. A., Murray, L. S., Reid, J. L., & Robertson, J. W. (1998). Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? The Lancet, 352, 179\u2013184.","journal-title":"The Lancet"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0002-9343(75)90395-2","volume":"59","author":"J Lieberman","year":"1975","unstructured":"Lieberman, J. (1975). Elevation of serum angiotensin converting enzyme (ACE) level in sarcoidosis. The American Journal of Medicine, 59, 365\u2013372.","journal-title":"The American Journal of Medicine"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1056\/NEJM197606242942609","volume":"294","author":"J Lieberman","year":"1976","unstructured":"Lieberman, J., & Beutler, E. (1976). Elevation of serum angiotensin-converting enzyme in Gaucher\u2019s disease. The New England Journal of Medicine, 294, 1442\u20131444.","journal-title":"The New England Journal of Medicine"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-87-4-422","volume":"87","author":"J Lieberman","year":"1977","unstructured":"Lieberman, J., & Rea, T. H. (1977). Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. Annals of Internal Medicine, 87, 423\u2013425.","journal-title":"Annals of Internal Medicine"},{"key":"27_CR22","doi-asserted-by":"publisher","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","volume":"295","author":"F Lovren","year":"2008","unstructured":"Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P. C., Levitt, K. S., Oudit, G. Y., Al-Omran, M., Stewart, D. J., Slutsky, A. S., Peterson, M. D., Backx, P. H., Penninger, J. M., & Verma, S. (2008). Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. American Journal of Physiology. Heart and Circulatory Physiology, 295, H1377\u2013H1384.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"27_CR23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1164\/ajrccm.157.5.9707141","volume":"157","author":"BT Mossman","year":"1998","unstructured":"Mossman, B. T., & Churg, A. (1998). Mechanisms in the pathogenesis of asbestosis and silicosis. American Journal of Respiratory and Critical Care Medicine, 157, 1666\u20131680.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"27_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","volume":"370","author":"A Patel","year":"2007","unstructured":"Patel, A., MacMahon, S., Chalmers, J., Neal, B., Woodward, M., Billot, L., Harrap, S., Poulter, N., Marre, M., Cooper, M., Glasziou, P., Grobbee, D. E., Hamet, P., Heller, S., Liu, L. S., Mancia, G., Mogensen, C. E., Pan, C. Y., Rodgers, A., & Williams, B. (2007). Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. The Lancet, 370, 829\u2013840.","journal-title":"The Lancet"},{"key":"27_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/FJC.0b013e3180986219","volume":"50","author":"MK Raizada","year":"2007","unstructured":"Raizada, M. K., & Ferreira, A. J. (2007). ACE2: A new target for cardiovascular disease therapeutics. Journal of Cardiovascular Pharmacology, 50, 112\u2013119.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"27_CR26","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1038\/sj.onc.1203969","volume":"19","author":"A Saaristo","year":"2000","unstructured":"Saaristo, A., Karpanen, T., & Alitalo, K. (2000). Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene, 19, 6122\u20136129.","journal-title":"Oncogene"},{"key":"27_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/cvr\/cvn170","volume":"80","author":"L Sanchez de Miguel","year":"2008","unstructured":"Sanchez de Miguel, L., Neysari, S., Jakob, S., Petrimpol, M., Butz, N., Banfi, A., Zaugg, C. E., Humar, R., & Battegay, E. J. (2008). B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart. Cardiovascular Research, 80, 106\u2013113.","journal-title":"Cardiovascular Research"},{"key":"27_CR28","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1161\/01.ATV.0000245821.77155.c3","volume":"26","author":"H Sano","year":"2006","unstructured":"Sano, H., Hosokawa, K., Kidoya, H., & Takakura, N. (2006). Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2673\u20132680.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"27_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1247\/csf.26.25","volume":"26","author":"M Shibuya","year":"2001","unstructured":"Shibuya, M. (2001). Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis. Cell Structure and Function, 26, 25\u201335.","journal-title":"Cell Structure and Function"},{"key":"27_CR30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1084\/jem.141.5.1084","volume":"141","author":"YA Sidky","year":"1975","unstructured":"Sidky, Y. A., & Auerbach, R. (1975). Lymphocyte-induced angiogenesis: A quantitative and sensitive assay for the graft-versus-host reaction. The Journal of Experimental Medicine, 141, 1084\u20131100.","journal-title":"The Journal of Experimental Medicine"},{"key":"27_CR31","first-page":"73","volume":"21","author":"P Skopi\u0144ski","year":"2001","unstructured":"Skopi\u0144ski, P., Sommer, E., Borowska, A., Hevelke, A., Rogala, E., & Skopi\u0144ska-Rozewska, E. (2001). Angiotensin-converting enzyme activity and angiomodulatory effects of sera in patients with diabetic retinopathy. International Journal of Clinical Pharmacology Research, 21, 73\u201378.","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"7","key":"27_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1465-9921-7-82","volume":"25","author":"A Tzouvelekis","year":"2006","unstructured":"Tzouvelekis, A., Anevlavis, S., & Bouros, D. (2006). Angiogenesis in interstitial lung diseases: A pathogenetic hallmark or a bystander? Respiratory Research, 25(7), 82.","journal-title":"Respiratory Research"},{"key":"27_CR33","doi-asserted-by":"publisher","first-page":"L351","DOI":"10.1152\/ajplung.00369.2007","volume":"294","author":"EJ Wagner","year":"2008","unstructured":"Wagner, E. J., Sanchez, J., McClintock, J. Y., Jenkins, J., & Moldobaeva, A. (2008). Inflammation and ischemia-induced lung angiogenesis. American Journal of Physiology. Lung Cellular and Molecular Physiology, 294, L351\u2013L357.","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"27_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.intimp.2007.07.022","volume":"8","author":"D Westermann","year":"2008","unstructured":"Westermann, D., Schultheiss, H. P., & Tschope, C. (2008). New perspective on the tissue kallikrein-kinin system in myocardial infarction: Role of angiogenesis and cardiac regeneration. International Immunopharmacology, 8, 148\u2013154.","journal-title":"International Immunopharmacology"},{"key":"27_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/01.HYP.25.5.913","volume":"25","author":"B Williams","year":"1995","unstructured":"Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995). Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension, 25, 913\u2013917.","journal-title":"Hypertension"},{"key":"27_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000069792","volume":"23","author":"H Yoshiji","year":"2002","unstructured":"Yoshiji, H., Kuriyama, S., & Fukui, H. (2002a). Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biology, 23, 348\u2013356.","journal-title":"Tumour Biology"},{"key":"27_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00001813-200203000-00003","volume":"13","author":"H Yoshiji","year":"2002","unstructured":"Yoshiji, H., Kuriyama, S., & Fukui, H. (2002b). Perindopril: Possible use in cancer therapy. Anti-Cancer Drugs, 13, 221\u2013228.","journal-title":"Anti-Cancer Drugs"},{"key":"27_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/1568009043332790","volume":"4","author":"H Yoshiji","year":"2004","unstructured":"Yoshiji, H., Kuriyama, S., Noguchi, R., & Fukui, H. (2004). Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy. Current Cancer Drug Targets, 4, 555\u2013567.","journal-title":"Current Cancer Drug Targets"},{"key":"27_CR39","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1182\/blood-2008-03-144766","volume":"112","author":"ET Zambidis","year":"2008","unstructured":"Zambidis, E. T., Park, T. S., Yu, W., Tam, A., Levine, M., Yuan, X., Pryzhkova, M., & P\u00e9ault, B. (2008). Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood, 112, 3601\u20133614.","journal-title":"Blood"},{"key":"27_CR40","first-page":"53","volume":"32","author":"TM Zielonka","year":"2007","unstructured":"Zielonka, T. M., Demkow, U., Filewska, M., Bia\u0142as, B., Korczynski, P., Szopinski, J., Soszka, A., & Skopinska-Rozewska, E. (2007a). Angiogenic activity of sera from interstitial lung diseases patients in relation to IL-6, IL-8, IL-12 and TNF\u03b1 serum level. Central European Journal of Immunology, 32, 53\u201360.","journal-title":"Central European Journal of Immunology"},{"issue":"Suppl. 5","key":"27_CR41","first-page":"767","volume":"58","author":"TM Zielonka","year":"2007","unstructured":"Zielonka, T. M., Demkow, U., Filewska, M., Golian-Geremek, A., Filewska, M., Zycinska, K., Bialas, B., Wardyn, K., & Skopinska-Rozewska, E. (2007b). TNF\u03b1 and INF\u03b3 inducing capacity of sera from interstitial lung diseases patients in relation to its angiogenesis activity. Journal of Physiology and Pharmacology, 58(Suppl. 5), 767\u2013780.","journal-title":"Journal of Physiology and Pharmacology"},{"issue":"Suppl. 2","key":"27_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/2047-783X-15-S2-229","volume":"15","author":"TM Zielonka","year":"2010","unstructured":"Zielonka, T. M., Demkow, U., Filewska, M., Radzikowska, E., Bialas, B., Filewska, M., Zycinska, K., Obrowski, M. H., Kowalski, J., Wardyn, K., & Skopinska-Rozewska, E. (2010). Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function. European Journal of Medical Research, 15(Suppl. 2), 229\u2013234.","journal-title":"European Journal of Medical Research"}],"container-title":["Advances in Experimental Medicine and Biology","Respiratory Regulation - The Molecular Approach"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-4549-0_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T02:28:27Z","timestamp":1676773707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-4549-0_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"ISBN":["9789400745483","9789400745490"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-4549-0_27","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[2012,6,29]]},"assertion":[{"value":"29 June 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}